John Koconis

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Campbell, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Joseph Lucchese, Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Koconis

Form 4 holding CEO & Chairman

Timber Pharmaceuticals, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
70,785
Estimated value
$115,309
Report date
20 Aug 2023
Price
$1.63
Ownership
Direct

Insider Reports Filed by John Koconis

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .